ticagrelor
- Product NDC
- 69238-1134
- 11-digit product format
- 692381134
- Labeler code
- 69238
- Product ID
- 69238-1134_6f0b5544-07cf-476e-98dd-61a85dd3e492
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ticagrelor
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- ANDA208531
- Marketing category
- ANDA
- Marketing start
- 2019-01-23
- Marketing end
- 0000-00-00
- Substance
- TICAGRELOR
- Active strength
- 90 mg/1
- Pharmacologic classes
- P2Y12 Platelet Inhibitor [EPC],Phenylalanine Hydroxylase Activators [MoA],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A5 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69238-1134 | TICAGRELOR TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 17 | Legacy NDC | 20250107_7cee944f-e2ca-4fc8-bb97-f46ca28728c5.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69238-1134-1 | 69238113401 | 100 TABLET in 1 BOTTLE (69238-1134-1) | 100 tablet | 2019-01-23 | 0000-00-00 | No | No | Current |
| 69238-1134-6 | 69238113406 | 60 TABLET in 1 BOTTLE (69238-1134-6) | 60 tablet | 2019-01-23 | 0000-00-00 | No | No | Current |